Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PAOX | Q6QHF9 | 3/20 | 0.48 |
| ▸ | KDM1A | O60341 | 4/20 | 0.46 |
| ▸ | SMOX | Q9NWM0 | 1/20 | 0.46 |
| ▸ | CNR1 | P21554 | 1/20 | 0.37 |
| ▸ | CNR2 | P34972 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | NPC1 | O15118 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17291826 | 1.00 | PAOX (0.48) | PAOXKDM1ASMOXCNR1CNR2 | |
| SCHEMBL17291824 | 1.00 | PAOX (0.48) | PAOXKDM1ASMOXCNR1CNR2 | |
| SCHEMBL17291829 | 1.00 | PAOX (0.48) | PAOXKDM1ASMOXCNR1CNR2 | |
| SCHEMBL5611725 | 1.00 | PAOX (0.48) | PAOXKDM1ASMOXCNR1CNR2 | |
| SCHEMBL17291817 | 1.00 | PAOX (0.48) | PAOXKDM1ASMOXCNR1CNR2 | |
| SCHEMBL17291809 | 1.00 | PAOX (0.48) | PAOXKDM1ASMOXCNR1CNR2 | |
| Hydrochloric Acid SCHEMBL3027761 | 0.97 | SMOX (0.50) | PAOXKDM1ASMOXCNR1CNR2 | |
| SCHEMBL3023756 | 0.97 | PAOX (0.50) | PAOXKDM1ASMOXCNR1CNR2 | |
| Hydrochloric Acid SCHEMBL3024738 | 0.94 | SMOX (0.52) | PAOXKDM1ASMOXKDM4EALDH1A1 | |
| SCHEMBL1948513 | 0.90 | KDM1A (0.43) | PAOXKDM1ASMOXKDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3168256-B1 | EYEWEAR MATERIAL COMPRISING A POLYURETHANE RESIN, EYEWEAR FRAME AND LENS | MITSUI CHEMICALS INC (JP) | 2019-08-07 | — | — | EP | disclosed |
| EP-3037411-B1 | 1,4-BIS(ISOCYANATOMETHYL)CYCLOHEXANE, POLYISOCYANATE COMPOSITION, POLYURETHANE RESIN, MOLDED ARTICLE, EYEWEAR MATERIAL, EYEWEAR FRAME AND LENS | MITSUI CHEMICALS INC (JP) | 2019-03-27 | — | — | EP | disclosed |
| EP-3168256-A1 | 1,4-BIS(ISOCYANATOMETHYL)CYCLOHEXANE, POLYISOCYANATE COMPOSITION, POLYURETHANE RESIN, MOLDED ARTICLE, EYEWEAR MATERIAL, EYEWEAR FRAME, AND LENS | Mitsui Chemicals, Inc. (JP) | 2017-05-17 | — | — | EP | disclosed |
| US-9477012-B2 | 1,4-bis(isocyanatomethyl)cyclohexane, polyisocyanate composition, polyurethane resin, molded article, eyewear material, eyewear frame, and lens | MITSUI CHEMICALS, INC. (JP) | 2016-10-25 | — | — | US | disclosed |
| US-9475903-B2 | 1,4-bis(isocyanatomethyl)cyclohexane, polyisocyanate composition, polyurethane resin, molded article, eyewear material, eyewear frame, and lens | MITSUI CHEMICALS, INC. (JP) | 2016-10-25 | — | — | US | disclosed |
| EP-3037411-A1 | 1,4-BIS(ISOCYANATOMETHYL)CYCLOHEXANE, POLYISOCYANATE COMPOSITION, POLYURETHANE RESIN, MOLDED PRODUCT, EYEWEAR MATERIAL, EYEWEAR FRAME AND LENS | Mitsui Chemicals, Inc. (JP) | 2016-06-29 | — | — | EP | disclosed |
| US-20150342276-A1 | 1,4-BIS(ISOCYANATOMETHYL)CYCLOHEXANE, POLYISOCYANATE COMPOSITION, POLYURETHANE RESIN, MOLDED ARTICLE, EYEWEAR MATERIAL, EYEWEAR FRAME, AND LENS | MITSUI CHEMICALS, INC. (JP) | 2015-12-03 | — | — | US | disclosed |
| US-20150346387-A1 | 1,4-BIS(ISOCYANATOMETHYL)CYCLOHEXANE, POLYISOCYANATE COMPOSITION, POLYURETHANE RESIN, MOLDED ARTICLE, EYEWEAR MATERIAL, EYEWEAR FRAME, AND LENS | MITSUI CHEMICALS, INC. (JP) | 2015-12-03 | — | — | US | disclosed |
| US-20100189679-A1 | CROSSLINKED POLYALLYLAMINE OR ACID ADDITION SALT THEREOF, AND USE THEREOF FOR MEDICAL PURPOSES | TORAY INDUSTRIES, INC. (JP) | 2010-07-29 | — | — | US | disclosed |
| EP-2168992-A1 | CROSSLINKED POLYALLYLAMINE OR ACID ADDITION SALT THEREOF, AND USE THEREOF FOR MEDICAL PURPOSES | Toray Industries, Inc. (JP) | 2010-03-31 | — | — | EP | disclosed |
| US-4588806-A | Polyphenylene ether resins having bimodal molecular weight distributions and method of their formation | GENERAL ELECTRIC COMPANY (US) | 1986-05-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100189679-A1 | CROSSLINKED POLYALLYLAMINE OR ACID ADDITION SALT THEREOF, AND USE THEREOF FOR MEDICAL PURPOSES | SLC6A12, SLC20A1, SLC20A2 | PAOX 1263/4885KDM1A 2719/4885SMOX 575/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.